Skip to content

Novel Esophago-Jejunal Anastomosis Method During Totally Laparoscopic Total Gastrectomy

Novel Esophago-Jejunal Anastomosis Method During Totally Laparoscopic Total Gastrectomy: π-shape Esophagojejunostomy, Three-in-one Technique

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02330913
Enrollment
10
Registered
2015-01-05
Start date
2014-12-31
Completion date
2015-10-31
Last updated
2015-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Keywords

total gastrectomy, intracorporeal, totally laparoscopic, esophagojejunostomy, anastomosis

Brief summary

Laparoscopic gastrectomy became a good option for early gastric cancer. Surgical trend is gradually changed to totally laparoscopic gastrectomy from laparoscopy-assisted gastrectomy requiring mini-laparotomy. Various types of intracorporeal anastomosis have been introduced for esophagojejunostomy during total gastrectomy. We invented a novel anastomosis method using linear stapler for total gastrectomy. Three procedures (Jejunal resection, esophageal resection and closure of common entry hole after anastomosis) was performed with only one stapler. Therefore, the novel method is simple and fast. Also, this new technique is better economically than previously introduced anastomosis using linear stapler because lesser number of stapler is required. We want to demonstrate the feasibility of novel intracorporeal anastomosis method during laparoscopic total gastrectomy.

Interventions

PROCEDUREIntracorporeal esophagojejunostomy

Under laparoscopic view, esophagojejunostomy was pereformed with 60mm linear stapler on right side of distal esophagus like as functional end-to-end fashion before esophageal and jejunal resection. Then, three procedures of esophageal resection, common entry hole closure and jejunal resection was performed with a single use of 60mm stapler. Also, jejunojejunostomy was also performed via already made staple entry hole.

Sponsors

Keimyung University Dongsan Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Histologically confirmed adenocarcinoma in stomach * Males or Females, aged≥20 years and ≤80 years * Without serosa invasion, extraperigastric lymph node metastasis and other organ metastasis stage in preoperative evaluation, (cT1-3N0-1M0) * Beyond the indication of ESD * Tumor location in high body of stomach or requiring total gastrectomy * Eastern Cooperative Oncology Group Performance Status (ECOG PS) of 0 or 1 at study entry * American Society of Anesthesiolosists (ASA) score of 1 to 3 * The patient has given their written informed consent to participate in the study

Exclusion criteria

* Simultaneous malignancy in other organ * Experience of previous laparotomy * Experience of gastric resection including wedge resection * Vulnerable subject

Design outcomes

Primary

MeasureTime frameDescription
Anastomosis related complication rateDuring 30 days after operationAnastomotic leakage, intraluminal bleeding, or stenosis were considered as anastomosis related complication

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026